Landscape analysis of synthetic polypeptides approved in the EU
Our work
Explore our recent work here and find out how we help organisations create value from knowledge.
Stimulating drug repurposing
Addressing global regulatory challenges of combination products
An assessment of the Commission’s criteria to define unmet medical need and high unmet medical need
Study in support of the evaluation and impact assessment of the EU general pharmaceutical legislation
Regulatory flexibilities and guidance for addressing the challenges of COVID-19 in the EU
Global Landscape of follow-on biologics
Pharmacovigilance of biologics
IMiPACT
